BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23726005)

  • 1. Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation.
    Venkatramani R; Kamath S; Wong K; Olch AJ; Malvar J; Sposto R; Goodarzian F; Freyer DR; Keens TG; Mascarenhas L
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):942-8. PubMed ID: 23726005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation.
    Venkatramani R; Kamath S; Wong K; Olch AJ; Malvar J; Sposto R; Goodarzian F; Freyer DR; Keens TG; Mascarenhas L
    Pediatr Blood Cancer; 2014 Jul; 61(7):1277-81. PubMed ID: 24482138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
    Koh ES; Sun A; Tran TH; Tsang R; Pintilie M; Hodgson DC; Wells W; Heaton R; Gospodarowicz MK
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):223-8. PubMed ID: 16904523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
    Wang SL; Liao Z; Vaporciyan AA; Tucker SL; Liu H; Wei X; Swisher S; Ajani JA; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):692-9. PubMed ID: 16242257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive models for pulmonary function changes after radiotherapy for breast cancer and lymphoma.
    Sánchez-Nieto B; Goset KC; Caviedes I; Delgado IO; Córdova A
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e257-64. PubMed ID: 21621341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
    Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis.
    Chang DT; Olivier KR; Morris CG; Liu C; Dempsey JF; Benda RK; Palta JR
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):125-31. PubMed ID: 16427214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for lung toxicity in pediatric cancer survivors].
    López Andreu JA; Compte Torrero L; Ferrís Tortajada J; Domenech Clar R; Pérez Tarazona S; Pellicer Porres C; Cortina Orts H; Roqués Serradilla JM
    An Esp Pediatr; 1999 Nov; 51(5):505-11. PubMed ID: 10652802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide.
    Hartsell WF; Czyzewski EA; Ghalie R; Kaizer H
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):69-73. PubMed ID: 7536723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest.
    Lewis GD; Agrusa JE; Teh BS; Gramatges MM; Kothari V; Allen CE; Paulino AC
    Pract Radiat Oncol; 2018; 8(5):e364-e368. PubMed ID: 29730281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and Late Pulmonary Effects After Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.
    Briere TM; Agrusa JE; Martel MK; Jackson A; Olch AJ; Ronckers CM; Kremer LCM; Constine LS; McAleer MF
    Int J Radiat Oncol Biol Phys; 2024 Jun; 119(2):533-548. PubMed ID: 35525723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
    Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates.
    Schallenkamp JM; Miller RC; Brinkmann DH; Foote T; Garces YI
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):410-6. PubMed ID: 17236964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy.
    Harder EM; Park HS; Chen ZJ; Decker RH
    Pract Radiat Oncol; 2016; 6(6):e353-e359. PubMed ID: 27156424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Normal tissue tolerance to external beam radiation therapy: lung].
    Ortholan C; Mornex F
    Cancer Radiother; 2010 Jul; 14(4-5):312-8. PubMed ID: 20591717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20 years of experience in static intensity-modulated total-body irradiation and lung toxicity. Results in 257 consecutive patients.
    Schneider RA; Schultze J; Jensen JM; Hebbinghaus D; Galalae R; Kimmig BN
    Strahlenther Onkol; 2007 Oct; 183(10):545-51. PubMed ID: 17896085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.